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Abstract 
Introduction: It is difficult to differentiate benign and malignant lesions just by histopathological evaluation due to lack of clear criteria of 
diagnosis. Moreover, the group of benign pathologies of parathyroids is not homogenous, and recurrence of symptoms of hyperparathy-
roidism after surgical management was also noted in this group. This complication is not always due to inappropriate surgical technique. 
The goal of this work was to find the relationship between cellular ploidy and proliferative activity of adenomas and hyperplasia of para-
thyroids and preoperative levels of calcium and parathormone in the serum of patients surgically treated for primary hyperparathyroidism. 
Material and methods: A total of 98 parathyroid glands were tested, of which 81 (82.7%) were from female patients and 17 (17.3%) from 
male; the age of the patients was from 22 to 82 years, with an average of 58 years. 
Results: In resected glands pathological evaluation showed the following results: in 53 (54.1%) adenoma was present, and in 45 (45.9%) 
there was hyperplasia. Sixty-seven of the samples (68.4%) were characterised as diploid and 31 (31.6%) as aneuploid. There is important 
positive correlation (r = 0.34595; p = 0.011) between the percentage of S-phase cells (% SPF) and calcium levels measured prior to surgical 
resection of adenoma. The further analysis of patients with adenoma characterised by aneuploidy proved a statistically valid, positive 
correlation between %SPF and ionised calcium levels in blood serum of patients both before (r = 0.7189; p = 0.003) and after the surgical 
treatment (r = 0.6313; p = 0.012).
Conclusions: 1. Benign lesions of parathyroid with ploidy indicates their heterogeneity. 2. In aneuploid benign adenomas of parathyroid 
glands an increased percentage of cells in S phase (% SPF) correlates with a high level of calcium in serum pre- and post-parathyroidectomy. 
(Endokrynol Pol 2021; 72 (1): 44–50)
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Introduction
The most successful and only curative approach of 
treatment of primary hyperparathyroidism (PHPT) 
is radical surgical management — resection of one 
or many pathological parathyroid glands. Long-term 
results after this procedure are usually positive. The 
etiology of PHPT is very diverse, it ranges from benign 
lesions (adenomas and hyperplasia) to malignant pro-
liferations (carcinoma). Unfortunately, it is very difficult 
to differentiate benign and malignant lesions just by 
histopathological evaluation due to lack of clear criteria 
of diagnosis [1–3]. The carcinoma is most commonly 
diagnosed if there is the presence of lesions, infiltra-
tion of neighbouring tissues and organs, the presence 
of metastasis in regional lymph nodes, and recurrence 
of hyperparathyroidism symptoms after treatment [4, 
5]. On the other hand, the group of benign pathologies 
of parathyroids is not homogenous, and recurrence of 
symptoms of hyperparathyroidism after surgical man-
agement was also noted in this group. Furthermore, 
this complication is not always due to inappropriate 
surgical technique.  
The goal of this work was to find the relationship 
between cellular ploidy and proliferative activity of 
adenomas and hyperplasia of parathyroids and pre-
operative levels of calcium and parathormone in the 
serum of the patients surgically treated for primary 
hyperparathyroidism. 
Material and methods
Study group was confined to 98 consecutive patients surgically 
treated for PHPT from 1.07.2017 to 30.06.2018, with diagnosis of 
adenoma or hyperplasia. Patients qualified to the research did not 
have any pathologies in the remaining parathyroid glands, which 
was confirmed by histopathological examination. Two indepen-
dent pathologists verified all histopathological samples. The data 
about diagnosis, qualification for surgical management, outcomes 
of treatment, and control postsurgical examination were obtained 
from medical archival documentation. 
Cytofluorimetric examinations were done in the Maria Skłodowska-
-Curie National Research Institute of Oncology in Krakow, at the 
Department of Cancer Pathomorphology. Materials from fresh 
samples of excised glands from previously diagnosed patients 
Prof. dr hab. n.med. Jacek Gawrychowski, Klinika Chirurgii Ogólnej i Chirurgii Endokrynologicznej Śląskiego Uniwersytetu  
Medycznego w Katowicach, ul. Batorego 15, 41–902 Bytom, tel: +48 (32) 786 15 18; e-mail: chirurgiabytom@sum.edu.pl
This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles  
and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially
45










measured pre- and post-operatively in patients with 
adenoma. (Fig. 2 A, B). Whereas, there was a significant 
positive correlation (r = 0.34595; p = 0.011) between 
%SPF and calcium levels measured prior to surgical 
resection of adenoma. The correlation was not observed 
after the surgical procedure (Fig. 2C, D). 
By contrast, after surgical resection of hyperplasia, 
the correlation between %SPF, PTH, and calcium levels 
in serum was not proven, either before surgery or after 
(Fig. 3A–D).  
The further analysis of patients with adenoma 
characterised by aneuploidy proved a statistically valid, 
positive correlation (r = 0.7189; p = 0.003) between 
%SPF and ionised calcium levels in blood serum of 
patients both before and after the surgical treatment 
(r = 0.6313; p = 0.012) (Fig. 4A, B).
On the other hand, such a correlation was not 
observed in analysis of PTH levels in the serum of the 
patients (Fig. 4C, D). 
There was also no significant correlation between 
%SPF and ionised calcium and PTH levels in blood 
serum before or after surgical management in patients 
with diploid adenoma (Fig. 5A–D).
Discussion
Parathyroid gland pathologies are very difficult to 
differentiate owing to the fact that there is no certain 
histopathological guidance or criteria for their diagno-
sis. Today’s method of analysis of samples under the 
microscope and classification the pathology upon the 
presence of fibrous capsule, fibrous trabeculae, mitotic 
figures, and invasion of vessels/capsule is insufficient. 
[1–4]. Furthermore, the differentiation between para-
thyroid carcinoma, atypical adenoma, typical adenoma, 
and hyperplasia is practically impossible [5]. 
In case of atypical adenoma, the tumour has some 
characteristics of carcinoma and adenoma, but de-
finitive diagnosis cannot be made upon the absence of 
some carcinoma features. A promising tool to help with 
diagnosis is cytofluorometry. Although due to the time 
consuming, expensive studies its use is limited [7, 8]. 
Even though it has been established that diagnosed 
aneuploidy by cytofluorometry is quite a good indica-
tor for malignancy in some cases of solid tumours and 
generally is connected with worse prognosis [9–11], 
unfortunately the data of usage of this modality in 
cases of parathyroid pathologies are sparse and hence 
are controversial [12–13]. 
It has been shown that there is a close relationship 
between DNA ploidy and tumour biological nature 
[2]. Although aneuploidy is connected with potential 
malignancy and is a bad prognostic factor, it is not 
an unequivocal indicator of carcinoma. In diagnosed 
with multiple endocrine neoplasm were excluded. Evaluation of 
ploidy and proliferation was made with the ModFit software. The 
histogram DNA classification based on the ploidy was performed 
in consistency with the works of Shankey et al. – DNA Cytometry 
Consensus Conference (1992) [6].
Diploid histograms were described when only one signal of fluo-
rescence was observed, suitable for cells in G0/G1 phase. Additional 
fluorescence signals and visible G2/M phase were criteria to classify 
the histogram as aneuploid. The level of aneuploidy was given as 
the DNA index (DI), meaning the ratio of fluorescence intensity for 
abnormal cells in phase G0/G1 to fluorescence intensity for normal 
cells in phase G0/G1. For diploid cells the DI was 1.0. 
Diploid histogram with coefficient variance (the width of fluores-
cence signal for normal cells in G0/G1 phase in half of its length) 
over 8% was considered unsuitable for analysis. For aneuploid 
histogram the percentage of cells in S phase was given only for 
aneuploid cells. The proliferation index (PI) states the sum of the 
percentage of cells in S, G2, and M phase. 
Statistical analysis 
StatSoft Inc. (2014) STATISTICA v.12. (data analysis software sys-
tem) was used in statistical analysis. After determining the data 
distribution with Shapiro-Wilk test for data with normal distribu-
tion, the examined groups were compared with Student’s t-test, 
and the Mann-Whitney test was used for data distribution other 
than normal.
For data with a normal distribution, Pearson’s linear correlation was 
used to confirm the relationship between the parameters studied, 
and Spearman’s rank order correlation was used for distribution 
other than normal.
The numerical amounts in the examined groups were compared 
using the χ2 test. The results are presented in the form of average, 
standard deviation, and minimum and maximum values, as well 
as absolute numbers and percentages.
Results
A total of 98 parathyroid glands were tested, of which 81 
(82.7%) were from female patients and 17 (17.3%) from 
male; the age of the patients was from 22 to 82 years, with 
an average of 58 years. In resected glands pathological 
evaluation showed the following results: in 53 (54.1%) 
adenoma was present and in 45 (45.9%) hyperplasia. 
Sixty-seven of the samples (68.4%) were characterised as 
diploid and 31 (31.6%) aneuploid. Further information is 
presented in Table 1, which shows that in the adenoma 
group of 53 patients, and in 45 treated for hyperplasia, 
the average parathyroid hormone (PTH) and ionised 
calcium levels decreased to the normal value. We might 
ask the question whether determination of ploidy val-
ues on parathyroid benign lesions would alter current 
clinical practice. But DNA analysis does not differentiate 
between normal glands and adenoma or hyperplasia.
The study did not provide a statistically significant 
correlation between the percentage of cells in S phase 
(%SPF) and the level of PTH and ionised calcium in the 
blood serum of patients in the whole group of benign 
lesions, which was measured both before and after the 
benign parathyroid lesion removal surgery (Fig. 1A–D).
After the analysis of the study, there was no evident 
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benign adenomas the percentage of aneuploidy varies 
between 5.4% and 60% [10–12], so DNA analysis sug-
gests that some parathyroid adenomas and hyperpla-
sia may contain a subset of tumours that could show 
biological malignancy if allowed to progress untreated.
In our research we observed aneuploidy in 32% of 
benign lesions. Considering only adenomas of para-
thyroids, the percentage was higher and on average 
was 40%. In hyperplasia we observed aneuploidy in 
22% of cases.  
The historical study of Bengston and Irvin of 
healthy, hyperplastic, and adenomatous parathyroids 
showed in the first two types only lesions of normal 
character — diploidy, only in adenoma did they observe 
also aneuploidy. On the other hand, according to our 
research, aneuploidy can also be found in parathyroid 
hyperplasia [10].
On behalf of the research, Bowlby suggests that 
benign lesions can contain potentially malignant cells 
that can become active if the lesion is not resected [12]. 
In light of this, the estimation of the value of aneuploidy 
as an indicator of malignancy in histologically benign 
lesions is still inconclusive. It suggests that even histo-
logically benign lesions with aneuploidy can be pre-
malignant, and patients with this diagnosis should be 
preventively monitored for a longer time after surgical 
treatment [14, 15]. A supporting factor for this approach 
is the fact the aneuploidy is an indicator of genetic in-
stability of the cell [16, 17]. It is currently believed that 
a histologically benign tumour with aneuploidy may be 







Number of patients 98 53 (54.1%) 45 (45.9%)
Gender
Males 17 (17.4%) 17 (17.4%) 12 (22.6%) 5 (11.1%)
0.133







Superior 23 (23.4%) 23 (23.4%) 12 (22.6%) 11 (24.4%)
0.180
Inferior 39 (39.8%) 39 (39.8%) 19 (35.9%) 14 (31.1%)
Left
Superior 16 (16.3%) 16 (16.3%) 5 (9.4%) 11 (24.5%)
0.180
Inferior 26 (26.5%) 25 (26.5%) 17 (32.1%) 9 (20.00%)
The cells ploidy
Diploidy 67 (68.4%) 67 (68.4%) 32 (60.4%) 35 (77. 8%)
0.065
Aneuploidy 31 (31.6%) 31 (31.6%) 21 (39.6%) 10 (22.2%)
DNA index in aneuploid lesions
< 1 8 6 2
> 1–1.5 12 8 4
> 1.5 11 7 4
% of S phase
(min–max) 0.1 – 5.7 0.1 – 31.5
0.138




423.62 ± 594.2 274.91 ± 326.4 0.138




1.51 ± 0.07 0.383
After 1.1 ± 0.19 0.378
PTH — parathyroid hormone; Ca++ — ionised calcium; SD — standard deviation
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Figure 1A–D. Correlation between the percentage of cells in S phase within benign lesions of parathyroid glands in blood serum 
of patients before (A) and after (B) surgery and ionised calcium before (C) and after surgery (D)
A B
C D
Figure 2A–D. Correlation between the percentage of cells in S phase in adenoma of parathyroid glands patients’ blood serum 
concentration of parathyroid hormone (PTH) before (A) and after (B) surgery and the concentration of ionised calcium before (C) 
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Figure 3A–D. Correlation between the percentage of cells in S phase in parathyroid hyperplasia and patients’ blood serum concentration 
before (A) and after (B) surgery and ionised calcium before (C) and after (D) surgery
A B
C D
Figure 4A–D. Correlation between the percentage of cells in S phase in aneuploid parathyroid adenomas and patients’ blood serum 
concentration before (A) and after (B) surgery and the concentration of parathyroid hormone (PTH) before (C) and after (D) surgery
A B
C D
p = 0,003 p = 0,012
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premalignant and should be followed with heightened 
awareness for a long postoperative period.
Other authors in their studies proved limited 
value of DNA ploidy in the diagnosis of endocrine tu-
mours. According to their results, diploid and aneuploid 
cell changes were found in healthy, hyperplastic, and 
carcinoid parathyroids [18–20].  
Those results show that the tetraploidy that is ob-
served in half of benign lesions and in some malignan-
cies requires further analysis and study. Tetraploidy 
could be responsible for the speed of cellular prolif-
eration [21, 22]. Our study showed on average 30% of 
tetraploid changes in adenomas and hyperplasia, which 
confirmed the statements of other authors. From the 
results we can cautiously conclude that even though 
the cellular DNA measurements have limited use, the 
presence of aneuploidy (also tetraploidy) can increase 
the risk of development of carcinoma [23].  
Rosen and Munchow confirmed that differentiation 
of healthy parathyroid from adenoma is practically 
impossible based only on cytofluorometry [13]. 
The higher concentration of calcium in patients’ serum 
with diagnosis of carcinoma is quite relevant [24]. How-
ever, we also observed a positive correlation (p = 0.003) 
between the percentage of cells in S phase and levels of 
calcium in the group of patients with benign lesions. The 
correlation was also observed post surgically. The results 
indicate that an increase in cellular proliferation stimulates 
an increase in calcium levels in serum. The proliferative 
activity of the tumour is established by calculation of 
the percentage of cells in S phase [2, 25]. Our study was 
able to define a subgroup of patients who showed DNA 
abnormalities that correlated with biochemical findings.
The increased number of cells in the S phase in solid 
tumours with aneuploidy is an established fact. Practi-
cally all authors agree that an increased percentage of 
cells in S phase is connected with increased proliferative 
activity of the tumour [2, 25].  
This correlation can testify the potential aggressive-
ness of aneuploid adenomas. This particular phenom-
enon can be a cause of increased calcium concentration 
in serum. In clinical practice, high levels of calcium are 
mostly found in parathyroid carcinomas [5, 25].  
Conclusions
Benign lesions of parathyroid with ploidy indicates 
their heterogeneity. 
In aneuploid benign adenomas of parathyroid 
glands an increased percentage of cells in S phase 
(%SPF) correlates with a high level of calcium in serum 
pre- and post-parathyroidectomy.  
Figure 5A–D. Correlation between the percentage of cells in S phase in diploid parathyroid adenomas and patients’ blood serum 
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